CLOs on the Move

Foghorn Therapeutics

www.foghorntx.com

 
More than 20,000 genes make us human. Genes control critical aspects of health and disease — but what controls our genes? Foghorn® Therapeutics ($FHTX) is developing therapies based on a system that directs which genes our cells express, and when, where, and in what order. By manipulating this system with our unique Gene Traffic Control™ platform, Foghorn will change how genes turn “on” and “off.” Unlike approaches that edit genes, this novel way of thinking will alter what our DNA has in store for us—and rewrite destiny for millions of people living with disease. With Gene Traffic Control™ Foghorn is ...
  • Number of Employees: 100-250
  • Annual Revenue: $10-50 Million
  • www.foghorntx.com
  • 500 Technology Square Suite 700
    Cambridge, MA USA 02139
  • Phone: 617.586.3100

Executives

Name Title Contact Details
Michael LaCascia
Chief Legal Officer Profile

Similar Companies

Cohort

Cohort`s mission is to transform the quality of patient`s lives with relationship based patient advocacy. Our Care Navigators are passionate, highly trained and carefully matched for each patient maximizing program efficacy.

HMS

HMS® (NASDAQ: HMSY) advances the healthcare system by helping healthcare organizations reduce costs and improve health outcomes. Through our industry-leading technology, analytics and engagement solutions, we save billions of healthcare dollars annually while helping consumers lead healthier lives. HMS provides a broad range of coordination of benefits, payment integrity and population health management solutions that help move the healthcare system forward.

Uroplasty

Uroplasty is a global medical company committed to offering transformative treatment options through specialty physicians. Our products are designed to help providers change the lives of their voiding dysfunction patients and strengthen the efficiency of their practices. Uroplasty’s products include the Urgent® PC Neuromodulation System, a non-drug, non-surgical office-based treatment for Overactive Bladder and associated symptoms of urinary urgency, urinary frequency and urge incontinence. Urgent PC is an FDA-cleared system that delivers PTNS (Percutaneous Tibial Nerve Stimulation) and is also indicated for the treatment of fecal incontinence outside the US market. Uroplasty also offers Macroplastique®, an injectable urethral bulking agent for female stress urinary incontinence primarily due to intrinsic sphincter deficiency. Female SUI only in U.S.; male and female SUI outside the U.S. Uroplasty products are typically used when a patient’s treatment goals are not met after conservative and/or drug therapies. Providers and patients alike appreciate that Uroplasty products provide low-risk, effective alternatives to invasive surgery. And because these treatments can be delivered in an office or outpatient setting, the end result is that more patients are given the opportunity to transform their lives with successful treatment.

Los Angeles Biomedical Research Institute

Los Angeles Biomedical Research Institute is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Los Angeles Biomedical Research Institute is based in Torrance, CA. You can find more information on Los Angeles Biomedical Research Institute at www.labiomed.org

Parrish Medical Center

Parrish Medical Center is one of the leading companies in Healthcare, Pharmaceuticals, & Biotech industry. Parrish Medical Center is based in Titusville, FL. You can find more information on Parrish Medical Center at www.parrishmed.com